Matches in SemOpenAlex for { <https://semopenalex.org/work/W2521731942> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2521731942 endingPage "189" @default.
- W2521731942 startingPage "179" @default.
- W2521731942 abstract "The peroxisome is an intracellular granule characterized by the presence of catalase, carnitine acetyltransferase and several hydrogen peroxide-generating enzymes, including the enzyme system involved in the β-oxidation of long-chain fatty acids. Clofibrate, as well as other potent hypolipidemic agents, causes massive hepatomegaly when administered to rodents, chickens and other species. This hepatomegaly is characteristically associated with a marked increase in the number and volume densities of peroxisomes in the liver. Furthermore, several studies have now established that certain chemicals (hypolipidemic peroxisome proliferators) induce hepatocellular carcinoma in both mice and rats. However, whether there is a direct interrelationship between the drug action, peroxisome proliferation and carcinoem genecity is yet to be established. In this revi, I have summarized recent publications concerning the effects of many chemicals on the characteristics of hepatic peroxisomes. The effects of these chemicals on peroxisomes (number, size and emzyme composition) are species-, sex-, and dose-depend. For example, clofibrate, nafenopin, Wy-14, 643, DEHP, etc induced hepatic peroxisome proliferation in the rodeuts. However, any damage of the liver and hepatic poroxisome proliferation in the human freintest with clofibrate or fenofibrate, were not found. On the other hand it is impotant finding for developing a new drug that certain hypolipidemic peroxisome proliferators induce hepatocarcinoma in rodents. However the species difference of the effect on hepatic peroxisomes is extremely marked, and also there is no report concernimg hepatocarcinogenesis by these drugs in human and other primates. As seen in this review, althongh there are many works concerning peroxisome protiferation, serum lipids level, hepatotoxicity, the interrelationship of these phenomena has not yet been elucidated. Then to understand the meanings of the changes in hepatic peroxisomes, it is essential for taking a new turn of the meanings of the changes in hepatic peroxisomes to analyze in detail many data for the mode of action, species difference and sexdiffernce of the effect of these drugs including the drugs other than hypolipidemic peroxisome proliferator." @default.
- W2521731942 created "2016-09-30" @default.
- W2521731942 creator A5073120991 @default.
- W2521731942 date "1986-01-01" @default.
- W2521731942 modified "2023-09-25" @default.
- W2521731942 title "Drugs and hepatic peroxisome proliferation." @default.
- W2521731942 doi "https://doi.org/10.2133/dmpk.1.179" @default.
- W2521731942 hasPublicationYear "1986" @default.
- W2521731942 type Work @default.
- W2521731942 sameAs 2521731942 @default.
- W2521731942 citedByCount "1" @default.
- W2521731942 crossrefType "journal-article" @default.
- W2521731942 hasAuthorship W2521731942A5073120991 @default.
- W2521731942 hasBestOaLocation W25217319421 @default.
- W2521731942 hasConcept C104317684 @default.
- W2521731942 hasConcept C126322002 @default.
- W2521731942 hasConcept C127078168 @default.
- W2521731942 hasConcept C134018914 @default.
- W2521731942 hasConcept C170493617 @default.
- W2521731942 hasConcept C181199279 @default.
- W2521731942 hasConcept C185592680 @default.
- W2521731942 hasConcept C188413054 @default.
- W2521731942 hasConcept C2778110834 @default.
- W2521731942 hasConcept C2778979269 @default.
- W2521731942 hasConcept C2779496979 @default.
- W2521731942 hasConcept C2779745421 @default.
- W2521731942 hasConcept C55493867 @default.
- W2521731942 hasConcept C63932345 @default.
- W2521731942 hasConcept C71924100 @default.
- W2521731942 hasConcept C86339819 @default.
- W2521731942 hasConcept C86803240 @default.
- W2521731942 hasConcept C98274493 @default.
- W2521731942 hasConceptScore W2521731942C104317684 @default.
- W2521731942 hasConceptScore W2521731942C126322002 @default.
- W2521731942 hasConceptScore W2521731942C127078168 @default.
- W2521731942 hasConceptScore W2521731942C134018914 @default.
- W2521731942 hasConceptScore W2521731942C170493617 @default.
- W2521731942 hasConceptScore W2521731942C181199279 @default.
- W2521731942 hasConceptScore W2521731942C185592680 @default.
- W2521731942 hasConceptScore W2521731942C188413054 @default.
- W2521731942 hasConceptScore W2521731942C2778110834 @default.
- W2521731942 hasConceptScore W2521731942C2778979269 @default.
- W2521731942 hasConceptScore W2521731942C2779496979 @default.
- W2521731942 hasConceptScore W2521731942C2779745421 @default.
- W2521731942 hasConceptScore W2521731942C55493867 @default.
- W2521731942 hasConceptScore W2521731942C63932345 @default.
- W2521731942 hasConceptScore W2521731942C71924100 @default.
- W2521731942 hasConceptScore W2521731942C86339819 @default.
- W2521731942 hasConceptScore W2521731942C86803240 @default.
- W2521731942 hasConceptScore W2521731942C98274493 @default.
- W2521731942 hasIssue "2" @default.
- W2521731942 hasLocation W25217319421 @default.
- W2521731942 hasOpenAccess W2521731942 @default.
- W2521731942 hasPrimaryLocation W25217319421 @default.
- W2521731942 hasRelatedWork W1497620344 @default.
- W2521731942 hasRelatedWork W1948212692 @default.
- W2521731942 hasRelatedWork W1989778505 @default.
- W2521731942 hasRelatedWork W2043573754 @default.
- W2521731942 hasRelatedWork W2065137782 @default.
- W2521731942 hasRelatedWork W2163771634 @default.
- W2521731942 hasRelatedWork W2397501423 @default.
- W2521731942 hasRelatedWork W2521731942 @default.
- W2521731942 hasRelatedWork W3025076848 @default.
- W2521731942 hasRelatedWork W4238501514 @default.
- W2521731942 hasVolume "1" @default.
- W2521731942 isParatext "false" @default.
- W2521731942 isRetracted "false" @default.
- W2521731942 magId "2521731942" @default.
- W2521731942 workType "article" @default.